<p>Raloxifene is an estrogen agonist/antagonist indicated for:</p>

<ul>
	<li>Treatment and prevention of osteoporosis in postmenopausal women</li>
	<li>Reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis</li>
	<li>Reduction in risk of invasive breast cancer in postmenopausal women at high risk for invasive breast cancer</li>
</ul>

<p>Important Limitations: Raloxifene is not indicated for the treatment of invasive breast cancer, reduction of the risk of recurrence of breast cancer, or reduction of risk of noninvasive breast cancer</p>